J. KNIPPER & COMPANY — Celecoxib Importer Profile
Pharmaceutical Importer · #5 buyer for Celecoxib · $5.2M import value · 220 shipments · UNITED STATES · DGFT Verified
J. KNIPPER & COMPANY is the #5 importer of Celecoxib from India with $5.2M in import value and 220 verified shipments. J. KNIPPER & COMPANY holds a 3.2% market share in Celecoxib imports based in UNITED STATES. The company sources from 1 verified supplier across 88 formulations shipped to 1 country. Overall, J. KNIPPER & COMPANY imports 28 pharmaceutical products worth $68.5M across 14 therapeutic categories.
J. KNIPPER & COMPANY — Celecoxib Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Celecoxib to J. KNIPPER & COMPANY?
Verified from 220 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ALEMBIC PHARMACEUTICALS LIMITED | $5.2M | 220 | 100.0% |
J. KNIPPER & COMPANY sources Celecoxib from 1 verified Indian supplier based on 220 customs records. The primary supplier is ALEMBIC PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does J. KNIPPER & COMPANY Compare to Nearest Celecoxib Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | UNITED STATES | $5.7M | 165 | $34.7K |
| 5 | J. KNIPPER & COMPANY ★ | UNITED STATES | $4.3M | 161 | $26.6K |
| 6 | NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $3.5M | 135 | $25.6K |
| 3 | NELPA LIFESCIENCES INC | PHILIPPINES | $3.4M | 68 | $50.0K |
J. KNIPPER & COMPANY ranks #5 among 781 Celecoxib importers from India. Average shipment value of $26.6K compared to the market average of $44.8K. The closest competitors by value are CIPLA USA INC UPS SUPPLY CHAIN SOLU and NORTHSTAR DISTRIBUTION CENTER 8912.
Where Does J. KNIPPER & COMPANY Import Celecoxib To?
Destination countries from 220 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $5.2M | 220 | 100.0% |
J. KNIPPER & COMPANY imports Celecoxib to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $5.2M.
What Celecoxib Formulations Does J. KNIPPER & COMPANY Import?
| Formulation | Value | Shipments |
|---|---|---|
| CELECOXIB CAPSULE 200 MG_100S_AP_US | $744.9K | 21 |
| CELECOXIB CAPSULE 100 MG_100S_AP_US | $445.6K | 20 |
| CELECOXIB CAPSULE 200 MG 100S AP US | $397.4K | 9 |
| CELECOXIB CAPSULE 100 MG 100S AP US | $242.5K | 10 |
| CELECOXIB CAPSULE 200 MG_500S_AP_US | $240.0K | 7 |
| CELECOXIB CAPSULE 200 MG_100S_AP_USNOS | $195.7K | 9 |
| CELECOXIB CAPSULE 200 MG_100S_AP_US DETAILS AS PER INVOICE | $150.0K | 3 |
| CELECOXIB CAPSULE 200 MG_100S_AP_US AS PER INVOICENOS | $146.0K | 6 |
| CELECOXIB CAPSULE 100 MG -100S -AP US | $136.0K | 4 |
| CELECOXIB CAPSULE 200 MG 500S AP USNOS | $132.5K | 6 |
J. KNIPPER & COMPANY imports 88 distinct Celecoxib formulations from India. The top formulation is CELECOXIB CAPSULE 200 MG_100S_AP_US with 21 shipments worth $744.9K.
Regulatory Requirements: Importing Celecoxib into United States
What J. KNIPPER & COMPANY and other importers must comply with to import Celecoxib from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Celecoxib
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Celecoxib from India and How Much Does J. KNIPPER & COMPANY Import?
India exported $35.0M worth of Celecoxib through 4,880 shipments from 326 suppliers to 112 countries, serving 781 buyers globally. J. KNIPPER & COMPANY imports $5.2M of this total, accounting for 3.2% of India's Celecoxib exports with 220 shipments from UNITED STATES. This is verified from 220 customs shipment records covering 88 distinct formulations.
What Is the Average Order Value for J. KNIPPER & COMPANY's Celecoxib Imports?
J. KNIPPER & COMPANY's average Celecoxib order value is $23.6K per consignment, based on 220 shipments totaling $5.2M. J. KNIPPER & COMPANY is based in UNITED STATES and ranks #5 among all Celecoxib importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Celecoxib to J. KNIPPER & COMPANY?
J. KNIPPER & COMPANY sources Celecoxib from 1 verified Indian supplier: ALEMBIC PHARMACEUTICALS LIMITED ($5.2M, 100.0%). This is based on 220 customs records.
How Does J. KNIPPER & COMPANY Compare to Other Celecoxib Importers?
J. KNIPPER & COMPANY ranks #5 among 781 Celecoxib importers from India with a 3.2% market share. The top 3 importers are CIPLA USA INC UPS SUPPLY CHAIN SOLU ($5.7M), J. KNIPPER & COMPANY ($4.3M), NORTHSTAR DISTRIBUTION CENTER 8912 ($3.5M). J. KNIPPER & COMPANY processed 220 shipments from UNITED STATES.
What Other Analgesics & Antipyretics Products Does J. KNIPPER & COMPANY Import?
J. KNIPPER & COMPANY also imports these analgesics & antipyretics products. Each links to the detailed product page.
About J. KNIPPER & COMPANY
J. KNIPPER & COMPANY imports 28 products worth $68.5M. Beyond Celecoxib, top products include Losartan, Valsartan, Doxycycline, Azithromycin, Fluoxetine. View the complete J. KNIPPER & COMPANY profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Celecoxib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Celecoxib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: J. KNIPPER & COMPANY matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as J. KNIPPER & COMPANY's capped import value divided by total capped export value for Celecoxib across all Indian exporters.
- 5.Verified Records: This page is backed by 220 individual customs records matching J. KNIPPER & COMPANY importing Celecoxib, covering 88 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 112+ countries, 781+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Celecoxib Import Data for J. KNIPPER & COMPANY
Access order-level details, pricing data, supplier connections, and competitive analysis for J. KNIPPER & COMPANY's Celecoxib imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
J. KNIPPER & COMPANY
Full Company Profile →
28 products · $68.5M total trade · 14 categories
J. KNIPPER & COMPANY × Celecoxib
Verified from customs records
Company Overview
Top Products by J. KNIPPER & COMPANY
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for J. KNIPPER & COMPANY.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Celecoxib. For current order-level data, contact TransData Nexus.